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 Abstract 
 Two recent health technology assessment (HTA) reports published in Germany focused on non-
pharmacological interventions for patients with dementia. One of the major results was the 
poor methodological quality of the studies in this field. This paper concisely presents the main 
quantitative and qualitative findings of the HTA report published by the German Agency for 
HTA at the Institute of Medical Information and Documentation (dahta    @    DIMDI), followed by a 
detailed discussion of the major methodological problems observed for the inclusion criteria, 
interventions, the setting, number of patients included, duration of observation, comparators, 
clinical endpoints, health economics, and, most obvious, the impossibility of blinding and elim-
inating placebo effects for future clinical studies. We conclude with several suggestions ad-
dressing these challenges for future research in this field.    Copyright © 2012 S. Karger AG, Basel 
 Introduction 
  Demographic changes will lead to an increasing number of patients with various forms 
of non-reversible dementia. Assuming a constant age-related prevalence, the number of de-
mented patients in Germany is likely to double by 2050   [1]  . No causal treatment of Alzhei-
mer’s dementia is available to date. Certain forms of early interventions such as changes in 
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lifestyle or an active reduction of certain risk factors may effectively reduce the burden soci-
ety will have to face, but from today’s perspective, more research is needed on these issues. 
Cholinesterase inhibitors and memantine are available as symptomatic antidementia drugs, 
but their importance for the treatment is still a matter of some debate   [2–5]  . Therefore, the 
development, improvement, and evaluation of non-pharmacological interventions for pa-
tients and/or caregivers represent an important task, which needs to be addressed with great-
er resolve and sophistication.
    The recent publication of two health technology assessment (HTA) reports in Germa-
ny – one from the German Institute for Quality and Efficiency in Health Care (IQWiG)   [6]   
and the other issued by the German Agency for Health Technology Assessment at the Insti-
tute of Medical Information and Documentation (dahta    @   DIMDI)  [7]  – reflects the growing 
public and scientific interest in non-pharmacological approaches. Both reports conclude that 
the scientific rigor of the studies examined was poor compared to the more straightforward 
randomized controlled and double-blind trials which have become the gold standard of clin-
ical psychopharmacology. The authors of both reports raised serious doubts about the valid-
ity of the studies on non-pharmacological interventions in dementia.
    Two other reviews   [8, 9]   additionally accounted for interventions focusing on the care-
givers and not the patients. Even though the evidence in this respect is stronger, both studies 
came to very similar conclusions. Olazarán et al.   [8]   state that, despite the high number of 
randomized controlled trials included in the analysis, the proportion of high-quality studies 
was low. Ayalon et al.   [9]   included only 3 randomized controlled trials (all of which evalu-
ated caregiving interventions) and 6 single-case study designs.
    From the existing literature, it appears unclear whether better-suited studies can be de-
signed and carried out. Potential theoretical shortcomings and practical pitfalls need to be 
identified and overcome preferably before further resources are invested in new trials. There-
fore, the results from one [7] of the HTA reports mentioned earlier form the basis for a de-
tailed discussion of specific problems, which need to be taken into account when designing 
future studies that evaluate nursing interventions in dementia. In the present paper, we try 
to identify and address the challenges lying ahead of researchers in this field. By doing so, 
the goal is to spark a discussion about potential methodological advances in order to improve 
the rigor of future studies and also to highlight a necessary differentiation from pharmaco-
logical research.
  To achieve this goal, the following Methods section illustrates the way relevant literature 
for this report was identified. The Results section then tries to focus on problems with study 
designs identified, while evaluating the available evidence. In the final chapter, the results 
are discussed and possible next steps towards a standardization of research in nursing inter-
ventions are highlighted.
  M e t h o d s  
 To identify the relevant literature for the scope of the HTA report, the search consisted of 
three different approaches: a systematic database search (e.g. in PubMed), a hand search in 
selected specific journals, and a request for papers in the pipeline but yet unpublished that 
was sent to relevant German institutions and experts involved in dementia care research. Nev-
ertheless, for the literature search, all international publications were considered. Only ran-
domized trials with a minimum number of 30 or more participants were included. In order 
to be able to cope with the magnitude of existing therapies, only studies on interventions that 
could be grouped into validation therapy/emotion-oriented care, occupational therapy, sen-
sory stimulation, relaxation techniques, reality orientation therapy, and reminiscence therapy 148
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were included following an expert panel discussion looking into the relative importance of 
different areas of possible interventions being performed in Western European countries. For 
a short description of the different interventions, refer to   table 1  . In most countries, these 
therapeutic concepts are carried out mainly by trained professionals (e.g. specialized nursing 
staff, psychologists, vocal or occupational therapists, etc.). Studies published before 1996 for 
the clinical part and before 1989 for the health economic part were excluded.
Table 1. S  hort description of the interventions
Nursing intervention Short description
Sensory stimulation
(Snoezelen)
This technique combines mild sensory stimuli (visual, aural, tactile, and 
olfactory stimuli) with relaxation. This way, a harmonically designed 
environment is meant to avoid deprivation, assist in stress reduction, and 
reduce aggressive behavior. No physical or intellectual requirements exist.
Multisensory stimulation emerged from the concept of Snoezelen. Specially 
equipped rooms are used to reinforce the senses. Other approaches also use 
sensory stimulation (e.g. music) but in general and not in such a 
comprehensive way [41].
Aromatherapy Aromatherapy is also a sensory approach. Essential oils are used for massages, 
bathing, or room flavor. The procedure is assumed to reduce stress and pain, 
cultivate recreative sleep, and positively influence depressive illnesses.
Aromatherapy may also form part of a multisensory approach [42].
Reality orientation
therapy
In this therapy, information is memorized and the orientation concerning 
place, time, and persons is reinforced. The basic idea is to enable the patients 
to better recognize their environment and, therefore, to develop more
self-control and self-confidence. The caregiver uses possibly every contact to 
involve the patients in a reality-oriented communication. Additionally, 
exercises (concerning for example date, weather, and name of meals) at a 
fixed schedule are done [43, 44].
Reminiscence therapy This therapy stems from the older reality orientation therapy. The main 
subject is the patient’s biography. Apart from talks, photographs, things, or 
even music from the patient’s past are used. It can be an individual or a group 
therapy [45].
Validation therapy/
emotion-oriented 
care
Validation is a process of verbal and non-verbal communication. The way the 
patients perceive their environment and their feelings are not corrected but 
respected and affirmed (validated). The goals are, among others, an improved 
self-esteem, stress reduction, and improved communication skills.
Emotion-oriented care is a combination of different approaches with 
validation being the core concept [43, 46].
Occupational therapy The central aspects of the occupational therapy are activities of daily living, 
such as getting dressed, using the bathroom, climbing stairs, or bathing. An 
essential part is the adaption of the environment to the patient’s diminishing 
abilities. Additionally, the day is structured with fixed times for meals,
care-giving activities, and repeating leisure times [47].
Relaxation techniques This is a general term for different techniques to reduce stress and relax. 
Often, autogenic training or progressive muscle relaxation are used. 
Autogenic training is a method of self-influence with the goal to induce 
relaxation. For progressive muscle relaxation, the muscles of certain body 
parts are alternately flexed and relaxed in order to induce relaxation [48].149
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c
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c
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c
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c
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c
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c
t
 
a
n
d
 
A
c
t
i
v
i
t
y
 
L
i
m
i
t
a
t
i
o
n
 
–
 
A
l
z
h
e
i
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c
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.
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r
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p
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i
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n
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c
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c
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b
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b
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c
e
s
N
o
 
d
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
i
n
t
e
r
v
e
n
t
i
o
n
 
a
n
d
 
c
o
n
t
r
o
l
 
g
r
o
u
p
s150
Dement Geriatr Cogn Disord Extra 2012;2:146–159
 DOI:  10.1159/000335777 
Published online: April 14, 2012
EXTRA
  Schwarzbach et al.: Why Is It So Difficult to Evaluate Nursing Interventions in Dementia? 
www.karger.com/dee
    © 2012 S. Karger AG, Basel
R
e
f
e
r
e
n
c
e
s
P
a
t
i
e
n
t
 
c
h
a
r
a
c
t
e
r
i
s
t
i
c
s
I
n
t
e
r
v
e
n
t
i
o
n
C
o
n
t
r
o
l
s
S
e
t
t
i
n
g
P
a
t
i
e
n
t
s
M
e
a
s
u
r
e
m
e
n
t
 
p
e
r
i
o
d
E
n
d
p
o
i
n
t
s
R
e
s
u
l
t
s
G
r
a
f
f
 
e
t
 
a
l
.
 
[
1
7
]
,
 
2
0
0
6
P
a
t
i
e
n
t
s
 
w
i
t
h
 
m
i
l
d
-
t
o
-
m
o
d
e
r
a
t
e
 
d
e
m
e
n
t
i
a
C
r
i
t
e
r
i
a
:
–
 
B
r
i
e
f
 
C
o
g
n
i
t
i
v
e
 
R
a
t
i
n
g
 
S
c
a
l
e
 
9
–
4
0
–
 
A
g
e
 
≥
6
5
 
y
e
a
r
s
–
 
P
a
t
i
e
n
t
 
l
i
v
e
s
 
a
t
 
h
o
m
e
–
 
P
r
i
m
a
r
y
 
c
a
r
e
g
i
v
e
r
 
e
x
i
s
t
s
O
c
c
u
p
a
t
i
o
n
a
l
 
t
h
e
r
a
p
y
U
s
u
a
l
 
c
a
r
e
H
o
m
e
 
c
a
r
e
n
 
=
 
1
3
5
(
l
o
s
t
 
t
o
 
f
o
l
l
o
w
-
u
p
:
 
1
5
%
)
6
 
w
e
e
k
s
–
 
A
s
s
e
s
s
m
e
n
t
 
o
f
 
M
o
t
o
r
 
a
n
d
 
P
r
o
c
e
s
s
 
S
k
i
l
l
s
 
–
 
P
r
o
c
e
s
s
 
S
c
a
l
e
–
 
I
n
t
e
r
v
i
e
w
 
o
f
 
D
e
t
e
r
i
o
r
a
t
i
o
n
 
i
n
 
D
a
i
l
y
 
A
c
t
i
v
i
t
i
e
s
 
i
n
 
D
e
m
e
n
t
i
a
 
–
 
P
e
r
f
o
r
m
a
n
c
e
 
S
c
a
l
e
P
o
s
i
t
i
v
e
 
e
f
f
e
c
t
s
 
o
f
 
t
h
e
 
i
n
t
e
r
v
e
n
t
i
o
n
 
o
n
 
a
l
l
 
e
n
d
p
o
i
n
t
s
B
a
k
e
r
 
e
t
 
a
l
.
 
[
1
8
]
,
 
1
9
9
7
P
a
t
i
e
n
t
s
 
w
i
t
h
 
A
D
,
 
v
a
s
c
u
l
a
r
 
o
r
 
p
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i
t
e
r
i
a
:
–
 
P
a
t
i
e
n
t
 
l
i
v
e
s
 
a
t
 
h
o
m
e
–
 
P
r
i
m
a
r
y
 
c
a
r
e
g
i
v
e
r
 
e
x
i
s
t
s
–
 
P
a
r
t
i
c
i
p
a
n
t
s
 
h
a
d
 
b
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c
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c
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n
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i
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d
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c
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c
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c
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i
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i
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  R e s u l t s  
 Database 
  Altogether, 1,658 clinical, 665 health economic, and 35 studies dealing with ethical or 
legal topics were identified in the structured literature search. Following the assessment of 
the abstracts by two independent reviewers, 287 clinical and 213 health economic publica-
tions were included for a closer examination of their relevance for the subject. Finally, 20 
clinical  [10–29]  and 6 health economic  [30–35]  publications met the inclusion criteria (details 
for the clinical part can be seen in   table 2  ).
    The 20 clinical publications presented results from 19 different studies from seven dif-
ferent countries. Of these 20 papers, 3 focused on validation therapy/emotion-oriented care, 
5 on manual therapy, 2 each on reality orientation and reminiscence therapy, 1 on a tech-
nique aimed at relaxation, and 7 on sensory stimulation. The latter are divided into 4 studies 
based on Snoezelen, and 1 study each on aromatherapy, music/massage, and therapeutic 
touch. These therapies are described in   table 1  .
    Ten studies reported no significant differences in comparing the intervention and the 
control group. The specific interventions in these studies were validation therapy/emotion-
oriented care, manual therapy, sensory stimulation, reminiscence therapy, and relaxation. 
Seven studies reported positive results in some of the observed aspects. Finally, 3 publica-
tions showed favorable results in all measured endpoints for a program of manual therapy, 
aroma therapy, and music/massage, respectively. An excerpt of relevant study data is pre-
sented in   table 2  .
    The identified publications presenting health economic findings were based on studies 
in four different countries. One study reported no significant differences in clinical out-
comes but an increase in costs due to an occupational therapy program. A slower decline in 
the Mini-Mental State Examination (MMSE) score in participating patients was claimed by 
2 Italian publications. However, the authors reported costs that omitted some important as-
pects of the intervention. The remaining 2 publications focused on a mix of interventions 
(an activity program and a special care program for still agile patients), therefore making it 
impossible to single out the effects of individual parts of the interventions.
    Overall, the studies included in the review were of poor methodological quality with a 
wide range of inclusion criteria, implementation and conduct of the interventions, study pe-
riods, settings, choice and design of the control groups, the number of patients enrolled, and 
the observed endpoints. The results were even less favorable for the health economic studies, 
providing too little information for any reliable conclusion. In the following part, the afore-
mentioned flaws of the studies will be presented in more detail.
    Based on the results of and explanations given in the systematic review of nursing inter-
ventions in dementia, the intention is to highlight the identified methodological problems in 
order to foster a scientific discussion around the question: ‘Why is it so difficult to conduct 
a scientifically sound study in the field of nursing interventions in dementia?’
  Inclusion  Criteria 
 While analyzing the publications for the systematic review, it became evident that many 
different instruments are used for the validation of a dementia diagnosis. Among the more 
frequently applied scales are the DSM-IV, the MMSE, the Clinical Dementia Rating Scale, 
and the Brief Cognitive Rating Scale. Unfortunately, there is still an ongoing controversial 
discussion on how all these scales can be linked or even transferred into one another. With 
that in mind, however, three categories (mild, moderate, and severe) are typically used to rate 
the severity of dementia. In addition to this rather rough estimation, the study population in 
most cases includes patients from different subgroups or even individuals without a diagno-153
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sis of dementia. In connection with small patient cohorts, this hinders a separate calculation 
for each subgroup, therefore reducing the chance to identify groups of patients that are like-
ly to benefit the most from an intervention.
    Obviously, ethical and legal considerations need to play a major role before including 
patients into a study. This holds true for both pharmaceutical and non-pharmaceutical in-
terventions. In the case of dementia, the autonomy of the participants is an issue, especially 
when thinking about informed consent to take part in a dementia study. So far, no standard 
for the inclusion has been established; therefore, these questions have to be raised for every 
single patient. Since, from a legal perspective, the patients will eventually lose their capacity 
to represent themselves, every single decision concerning the patient, and therefore also the 
decision to take part in a study, might also have to be taken by an appointed legal represen-
tative.
  I n t e r v e n t i o n s  
 In order to conduct an interventional study, the exact procedure has to be described first. 
For nursing interventions in dementia, the field of possible interventions is – as in other in-
dications – quite diverse, and their differentiation is not always clear. An example might be 
music therapy, which is a single intervention but can also be subsumed as part of a sensory 
stimulation program.
    The origin of these challenges goes as deep as to the fundamental underlying concepts 
for these interventions. In general, many different sensory, environmental, and cognitive 
treatments can be grouped under this topic. Some interventions are based on a complete shift 
in the way care is delivered, while others will be given only temporarily in class type forms. 
These differences may also have an influence on the amount of time and effort spent for a 
specific intervention.
    Talking about similarities and differences between different approaches, a standard 
within specific interventions seems to be far from common. This makes it difficult to even 
compare treatments bearing the same name. Additionally, the way an intervention is deliv-
ered differs from one caregiver to another, which might sometimes be due to the need for 
specific adaptations of a program caused by the situation of one patient. However, another 
source for these differences might also be added requirements for caregivers. On the one 
hand, the study protocol often requires them to change their usual routine entailing a chance 
to possibly improve their work, while, on the other hand, they have to follow a tight schedule 
or they even (e.g. in case of family caregivers) might lack the necessary education.
    As a result of these challenges, it should be worthwhile to define specific interventions 
in a stricter manner so that differences are reduced. Secondly, in order to alter or formalize 
the role of caregivers at the start of an intervention, this group needs to be given more train-
ing and time for them to learn, apply, and get used to the respective new method.
  S e t t i n g  
  In outpatient as well as inpatient care, a wide array of different treatments is possible. 
Especially in an ambulatory setting, an additional objective of any intervention will be the 
reduction of the burden of care for family caregivers. A reduced burden of care might actu-
ally prolong the period of outpatient care, avoiding or at least delaying nursing home admis-
sions. This may lead to a reduction in the direct costs for the social security system on the 
one hand, but potentially raises costs for family caregivers on the other. Interventions in both 
settings are of course worth to be investigated since the treatment usually takes place in an 
outpatient setting in early stages of the disease and is later shifted towards a higher degree of 
inpatient treatment. Studies in this field should account for differences in the environment 
or in the existing knowledge of the caregivers.154
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    The setting can also be biased by different study countries, leading to a wide variety of 
health care systems in which the intervention is applied. From the 19 clinical studies includ-
ed in the aforementioned systematic review, 7 were conducted in the USA, 4 each in the 
Netherlands and Great Britain, and 1 each in Italy, Canada, and China. One study was con-
ducted in Great Britain, the Netherlands, and Sweden at the same time. This further com-
plicates an analysis of the different treatments.
    Number of Patients Included and Duration of Observation 
  In comparison to studies with pharmacological interventions, the number of patients 
included was rather small and the duration of observation tended to be short. Only very few 
studies considered in our systematic review included more than 200 patients. The observa-
tion period differed substantially, ranging from a minimum of 1 h to a maximum of 52 
weeks. This problem obviously also touches ethical and legal problems for the inclusion of 
patients as longer observation periods also translate into longer time spans for the control 
group without the presumably favorable intervention. However, it also raises an economic 
question since bigger and longer-lasting studies require more funding. On the other hand, a 
higher number of patients facilitates the detection of significant results. As a consequence, 
the outcomes of smaller and shorter studies are very likely to have a lower statistical and 
clinical level of evidence and resulting validity. For future studies, it has to be discussed what 
time horizon and number of patients are appropriate to show meaningful clinical and ther-
apeutically relevant differences between the intervention and the control group.
  C o m p a r a t o r s  
 An additional aspect of differences is the choice of the respective comparator. Most stud-
ies analyzed in the systematic review compared the interventions with a standard care proce-
dure, an alternative program, or a combination of these. What this ‘standard of care’ includes 
is not answered in any study. Hence, the same challenges as described for differences in the 
intervention also apply for the definition of the comparators since it is quite likely that the 
properties of the control groups will vary across studies. One question that has to be raised at 
this point is, if it is possible at all, to identify or agree on a standard of care. Usually, study 
results rely on differences in effects between the novel intervention and the standard of care 
at a given time in the respective field. Lacking this foundation complicates the interpretation 
of all study findings, even if the difference was positive in a respective study. Furthermore, 
studies comparing a novel intervention to standard care are more likely to yield significant 
results, which is not the case for studies with an alternative program for the controls group. 
In that case, the majority of studies report no significant differences between the two groups.
    Additionally, the results for controls receiving standard care may also be diluted by ex-
ternal effects of an intervention on the comparators. One study mentioned possible positive 
effects on the controls because of a changed behavior of caregivers in an inpatient setting. 
This might have resulted from an increased attention and recognition for the work done in 
the hospital ward, as well as the availability of more time for patients in the control arm since 
the others were taken care of in the intervention. One possible interpretation for this finding 
could be that the effects are not caused by specific characteristics of the intervention itself 
but at least partly rest upon factors such as increased attention, devotion, and engagement.
    Studies in the area of non-pharmacological interventions also have to deal with poten-
tially huge confounding effects arising from the underlying pharmacological treatment pa-
tients receive. In this sense, results could be negatively biased even if the groups are well de-
signed, and this factor has been accounted for by the researchers. On the other hand, an 
intervention might very well struggle with the fact that it has to add positive effects on top 
of the impact of an ongoing drug therapy.155
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  Clinical  Endpoints 
  Evidence for disease-specific clinical endpoints derived by high-level controlled trials is 
requested by all drug authorization agencies. For the design of studies with a pharmaceutical 
agent, appropriate endpoints and respective validated instruments aiming at catching effects 
are more or less well known and accepted in dementia. For non-drug interventions, how-
ever, the issues of relevant outcomes, endpoints, and measures which might be used to collect 
data are different and challenging. In general, no specific guidance can be found in the lit-
erature on what to include in studies, and by looking at dementia as a broad group of differ-
ent diseases, the available body of evidence gets sparser the lower the prevalence of the indi-
cation. Research in the area of dementia care covers a wide range of endpoints aiming at 
objectives as diverse as cognitive and linguistic capabilities, the capacity for remembering 
facts and things, agitation, social behavior, controlling aggressiveness or anxiety, overcom-
ing apathy, dealing with depression (also by caregivers), coping with the mental burden
in general, fitness for everyday life, and positively impacting the quality of life of patients
and their caregivers. By doing so, a wide array of different questionnaires is utilized in prac-
tice – sometimes even to capture the same domains of interest. In most cases, these question-
naires have not been validated in a scientifically sound way, which, at the end, leads to using 
non-validated and probably inappropriate measures of which the results cannot be inter-
preted. A lot of research in this field has been done with respect to pharmacological inter-
ventions in dementia care. Such research also needs to be carried out for non-pharmacolog-
ical interventions. One result of this might be a reduction of the range of different measures, 
which would allow for less complex comparisons of findings from different studies.
  Health  Economics 
  In almost every case, health economic information provided by authors in this field 
does not follow internationally accepted standards (for Germany, refer to   [36]  ). The most 
basic questions, e.g. the adopted perspective, are not reported or discussed, not to mention 
a missing distinction between different types of costs and their quantities. Therefore, the 
transferability of results from one regulatory framework to another is strongly limited. Even 
within the respective health care system of a study, only limited economic implications can 
be inferred in most cases, as these flaws hinder the interpretation of the results. Researchers 
in this area should therefore start to adopt standards that are already well accepted in stud-
ies with pharmacological interventions, either internationally or at least in their respective 
country.
  Discussion 
  The concept of evidence-based medicine has been introduced two decades ago and has 
been enhanced up to now. For pharmaceutical products, requirements for study protocols 
and their methodological backbone have been harmonized mainly driven by formal require-
ments imposed by market authorization agencies like the FDA and the EMEA. As a result, 
the quality of pharmaceutical trials and studies has increased dramatically with respect to 
their methodology as well as their presentation of the results in journal articles or other pub-
lications.
    Since HTA agencies such as the NICE in England and Wales or the IQWiG and the 
DIMDI in Germany do not only assess drugs but increasingly also consider medical devices, 
procedures, and non-medical interventions (e.g. nursing interventions) for evaluation, it is 
only logical that it should at least be tried to apply and/or adopt the basic concepts of evi-
dence-based medicine to these health interventions as well   [37–39]  .156
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  In recent years, the methodological development focused primarily on pharmacological 
studies, which is why a widely accepted and sound framework exists. However, the gold stan-
dard concentrating on double-blind, controlled, and randomized settings obviously raises 
some major challenges for the conduct of studies in non-pharmacological interventions in 
demented patients. It is evident that in these indications at least health care providers and, 
to a great extent, also the people collecting the data can hardly be put in a blinded situation 
when conducting these studies. This can be seen as a major drawback, leading to the conclu-
sion that, regardless of the setting, doubts about the true efficacy of an intervention will re-
main. The randomization of study subjects also raises problems, but these might be met by 
a randomization of study centers, where different study sites – be it an inpatient or outpatient 
setting – conduct only one kind of intervention. This way, every participating branch does 
something else, which is why even an unchanged treatment provides useful insight. Of 
course, this leaves plenty of room for possible biases of all different kinds, starting with se-
lection biases or issues concerning different skills of the therapists. Nevertheless, all these 
problems that arise when benchmarking the quality of studies in this health care sector with 
the design of clinical trials for pharmaceuticals might not be overcome but at least be ad-
dressed with very rigorous transparency about the study design. On a separate note, some of 
the challenges just discussed are not exclusive to non-pharmaceutical interventions in de-
mentia. A great majority of medical devices are also facing these hurdles, which will be ad-
dressed by HTA agencies in the near future.
    For care interventions in dementia, only a limited amount of qualitatively good studies 
can be found (e.g.   [17]  ), which, in turn, suggests that it is possible to conduct well-designed 
studies also in this field. Nevertheless, the majority of the publications is of poor quality; 
hence, there is still a lot of work ahead for researchers in this field.   Table 3   gives an overview 
of useful next steps to achieve a common denominator for future studies.
    Obviously, a major part of the problem is the lack of financial resources for this kind of 
research. Especially aspects like the number of included patients or the time of follow-up are 
affected by this problem, which cannot easily be solved in face of a low public interest. Nev-
ertheless, a few of the other topics mentioned above (e.g. a standardization of the interven-
tions and endpoints) could be solved or at least be worked on irrespective of the funding. The 
recent attempt by Moniz-Cook et al.  [40]  might serve as an example to identify valid outcome 
measures for dementia care.
  In summary, it needs to be highlighted that, even though studies in this field show weak-
nesses on some basic requirements, this lack of evidence does not necessarily imply a lack of 
Table 3. N  ext steps to identify a standard in studies for nursing interventions
Area Challenge
Inclusion criteria Identify and agree upon a common measurement for the diagnosis
Interventions/comparators Thoroughly describe and, if possible, define standards for different 
interventions
Settings Carefully and thoroughly describe the environment
Number of patients included
and duration of observation
Concentrate on large-scale studies for interventions that have shown to 
be promising
Clinical endpoints Identify and agree upon a common set of validated instruments
Health economics Adopt established and accepted methods157
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efficacy and efficiency of these non-pharmaceutical interventions. This finding only empha-
sizes the need for additional and methodologically robust studies that also take into account 
the circumstances under which dementia care is provided in their specific context.
    The most obvious and striking problem with non-pharmacological interventions stud-
ied in patients with dementia is the impossibility of avoiding placebo and/or setting effects 
by systematic blinding. This methodological difficulty cannot be overcome by the most so-
phisticated designs as the interventions under scrutiny can be seen, heard, and felt. The lat-
ter sentence aims to point out the comparable simplicity of pharmacological studies and the 
notion that, by posing unrealistic barriers of methodological requirements for researchers in 
the field of nursing interventions, attempts at studying more ambitious and adequate meth-
ods of care will be hindered.
    Arguments calling for fairness in enabling comparisons of different techniques, the ne-
cessities of an increasing population of dementia patients, and political as well as economic 
requirements make the development and, consequently, the deployment of sound methods 
unavoidable and urgent. This is also reasonable as it could provide a common ground for 
comparisons of different kinds of interventions. In the end, the goal has to be the identifica-
tion of effective and efficient interventions for the increasing number of patients.
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